1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Chung, D.A.
Zuiderweg, E.R.
Neubig, R.R.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
41
3596
3604
10.1021/bi015811+
11888275
NMR structure of the second intracellular loop of the alpha 2A adrenergic receptor: evidence for a novel cytoplasmic helix.
2002
10.2210/pdb1ho9/pdb
pdb_00001ho9
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
3796.449
ALPHA-2A ADRENERGIC RECEPTOR
SECOND INTRACELLULAR LOOP (RESIDUES 118-149)
D130I
1
syn
polymer
ALPHA-2A ADRENOCEPTOR
no
no
TSSIVHLCAISLIRYWSITQAIEYNLKRTPRR
TSSIVHLCAISLIRYWSITQAIEYNLKRTPRR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2002-07-24
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
Mean structure of Wild-type T3-I2 peptide
Best 20 DYANA conformers of wild-type T3-I2 peptide
Mean structure of D130I mutant T3-I2 peptide
RCSB
Y
RCSB
2000-12-10
REL
REL
THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE OF THE PEPTIDE OCCURS NATURALLY IN HOMO SAPIENS (HUMAN).
sample
target function
100
20
2D NOESY
2D TOCSY
2D COSY
50 mM NACL
4.50
303.00
K
50 mM
4.50
303.00
K
SIMULATED ANNEALING IN TORSION ANGLE SPACE
0.9 mM PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5
90% H2O/10% D2O
0.9 mM PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5
100% D20
Guntert
structure solution
DYANA
Bartels
data analysis
XEASY
Delaglio
processing
NMRPipe
Johnson
data analysis
NMRView
Glaser
data analysis
SPSCAN
Guntert
refinement
DYANA
800
Varian
INOVA
THR
1
n
1
THR
1
A
SER
2
n
2
SER
2
A
SER
3
n
3
SER
3
A
ILE
4
n
4
ILE
4
A
VAL
5
n
5
VAL
5
A
HIS
6
n
6
HIS
6
A
LEU
7
n
7
LEU
7
A
CYS
8
n
8
CYS
8
A
ALA
9
n
9
ALA
9
A
ILE
10
n
10
ILE
10
A
SER
11
n
11
SER
11
A
LEU
12
n
12
LEU
12
A
ILE
13
n
13
ILE
13
A
ARG
14
n
14
ARG
14
A
TYR
15
n
15
TYR
15
A
TRP
16
n
16
TRP
16
A
SER
17
n
17
SER
17
A
ILE
18
n
18
ILE
18
A
THR
19
n
19
THR
19
A
GLN
20
n
20
GLN
20
A
ALA
21
n
21
ALA
21
A
ILE
22
n
22
ILE
22
A
GLU
23
n
23
GLU
23
A
TYR
24
n
24
TYR
24
A
ASN
25
n
25
ASN
25
A
LEU
26
n
26
LEU
26
A
LYS
27
n
27
LYS
27
A
ARG
28
n
28
ARG
28
A
THR
29
n
29
THR
29
A
PRO
30
n
30
PRO
30
A
ARG
31
n
31
ARG
31
A
ARG
32
n
32
ARG
32
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
2
A
A
O
H
ILE
TRP
13
16
1.56
4
A
A
O
H
ILE
ARG
10
14
1.56
8
A
A
O
H
VAL
ALA
5
9
1.58
9
A
A
O
H
VAL
ALA
5
9
1.60
10
A
A
O
H
CYS
LEU
8
12
1.51
10
A
A
O
H
LEU
SER
7
11
1.59
11
A
A
O
H
CYS
LEU
8
12
1.54
11
A
A
O
H
LEU
SER
7
11
1.58
12
A
A
O
H
LEU
SER
7
11
1.53
12
A
A
O
H
ILE
ALA
18
21
1.57
13
A
A
O
H
LEU
SER
7
11
1.52
16
A
A
O
H
ALA
ILE
9
13
1.59
18
A
A
O
H
ILE
ALA
18
21
1.52
18
A
A
O
H
ILE
CYS
4
8
1.53
1
A
SER
17
-67.99
67.58
1
A
ILE
18
-160.39
-44.88
1
A
ALA
21
-108.82
69.23
1
A
ARG
28
-43.95
166.33
1
A
THR
29
62.03
66.19
1
A
ARG
31
61.10
142.32
2
A
CYS
8
-145.98
-63.59
2
A
SER
11
-91.17
44.97
2
A
SER
17
-67.07
70.23
2
A
ILE
18
-164.53
-43.82
2
A
ILE
22
-151.30
-70.95
2
A
THR
29
62.70
69.66
2
A
ARG
31
51.72
101.04
3
A
CYS
8
-152.13
-65.73
3
A
SER
11
-91.15
37.10
3
A
ILE
13
-138.90
-50.83
3
A
TYR
15
-95.02
32.30
3
A
ILE
18
-144.20
-47.37
3
A
ALA
21
-103.52
66.39
3
A
LEU
26
-44.43
-70.77
3
A
THR
29
-157.78
87.36
3
A
ARG
31
-178.08
136.12
4
A
SER
17
-69.00
63.77
4
A
ILE
18
-155.43
-46.01
4
A
ALA
21
-116.48
56.31
4
A
ILE
22
-147.08
-62.11
4
A
LEU
26
-91.66
53.88
4
A
LYS
27
-177.20
64.92
4
A
ARG
31
-179.97
96.75
5
A
SER
17
-62.79
79.33
5
A
ILE
18
-176.75
-39.43
5
A
ALA
21
-115.80
68.25
5
A
LYS
27
-174.43
67.08
5
A
THR
29
52.13
81.04
6
A
CYS
8
-154.99
-63.39
6
A
SER
11
-104.67
44.55
6
A
ILE
13
-54.51
-74.22
6
A
ARG
14
-38.83
-29.91
6
A
TYR
15
-90.78
43.68
6
A
ILE
18
-145.36
-47.34
6
A
ALA
21
-112.22
67.18
6
A
ILE
22
-131.15
-59.76
6
A
LEU
26
-105.17
59.27
6
A
LYS
27
-173.64
64.94
7
A
SER
17
-66.63
70.92
7
A
ILE
18
-177.07
-39.19
7
A
ILE
22
-128.02
-58.76
7
A
ARG
31
172.80
110.00
8
A
SER
11
-99.26
35.66
8
A
ILE
13
-63.99
-79.32
8
A
ARG
14
-38.76
-29.97
8
A
TYR
15
-90.34
43.13
8
A
ILE
18
-148.80
-47.10
8
A
ALA
21
-101.66
-93.23
8
A
ILE
22
66.76
-72.17
8
A
LYS
27
56.64
79.12
8
A
ARG
28
65.24
135.97
9
A
SER
11
-93.64
44.60
9
A
LEU
12
-141.25
-55.05
9
A
SER
17
-69.42
60.27
9
A
ILE
18
-160.42
-44.60
9
A
ALA
21
-105.43
60.27
9
A
ILE
22
-123.13
-54.56
9
A
ARG
31
40.64
84.57
10
A
SER
17
-69.65
60.54
10
A
ILE
18
-142.36
-47.38
10
A
ILE
22
-143.79
-67.00
10
A
LYS
27
-121.86
-131.57
10
A
ARG
28
-178.97
149.17
10
A
THR
29
38.86
81.46
11
A
ILE
18
-148.01
-47.20
11
A
LYS
27
-164.54
88.57
11
A
ARG
28
-179.36
114.60
12
A
SER
11
-108.42
75.79
12
A
LEU
12
-134.48
-59.36
12
A
SER
17
-69.39
61.88
12
A
ILE
18
-153.05
-46.42
12
A
ILE
22
-145.34
-69.62
12
A
ARG
31
66.97
138.13
13
A
SER
11
-109.86
76.52
13
A
LEU
12
-136.20
-53.71
13
A
ILE
13
-61.08
-70.55
13
A
SER
17
-69.48
60.43
13
A
ILE
18
-160.37
-44.56
13
A
ILE
22
-131.42
-66.88
13
A
LYS
27
67.51
71.67
13
A
ARG
31
179.94
146.84
14
A
SER
3
-94.25
44.24
14
A
ILE
4
-147.82
-59.64
14
A
CYS
8
-152.16
-68.46
14
A
SER
11
-94.42
32.56
14
A
ILE
13
-58.39
-71.66
14
A
ARG
14
-38.78
-29.98
14
A
TYR
15
-90.76
44.76
14
A
ILE
18
-149.79
-46.95
14
A
ALA
21
-111.27
66.77
14
A
ILE
22
-134.96
-50.62
14
A
LYS
27
39.07
62.61
15
A
SER
11
-90.39
44.25
15
A
LEU
12
-102.54
-60.19
15
A
ILE
18
-143.99
-47.42
15
A
ALA
21
-102.83
70.23
15
A
LYS
27
-124.01
-131.64
15
A
ARG
28
61.12
113.64
15
A
ARG
31
56.05
102.23
16
A
ALA
21
-99.92
-94.18
16
A
ILE
22
66.69
-72.07
16
A
LYS
27
-120.86
-131.53
16
A
ARG
28
62.28
86.11
17
A
SER
2
-104.12
44.96
17
A
SER
3
177.42
-35.70
17
A
CYS
8
-151.04
-63.99
17
A
SER
11
-90.36
41.36
17
A
LEU
12
-144.18
-68.62
17
A
ILE
13
-52.79
-72.76
17
A
ARG
14
-38.71
-30.06
17
A
TYR
15
-90.64
44.56
17
A
ILE
18
-150.55
-46.86
17
A
ALA
21
-106.19
64.10
17
A
ARG
28
-45.93
152.44
17
A
THR
29
-152.16
75.50
18
A
ILE
4
-134.63
-64.30
18
A
SER
11
-88.51
44.69
18
A
LEU
12
-124.66
-58.89
18
A
SER
17
-69.55
60.99
18
A
ILE
18
-144.82
-47.30
18
A
ARG
28
-177.95
80.42
18
A
THR
29
-36.78
97.66
19
A
SER
11
-100.62
40.29
19
A
LEU
12
-141.30
-64.81
19
A
SER
17
-68.39
65.73
19
A
ILE
18
-157.39
-45.51
19
A
LYS
27
-175.09
115.83
19
A
ARG
28
-173.09
115.54
19
A
ARG
31
-177.63
109.01
20
A
SER
11
-109.01
76.34
20
A
LEU
12
-169.94
-64.29
20
A
SER
17
-69.36
61.88
20
A
ILE
18
-145.68
-47.22
20
A
ALA
21
-114.79
57.42
20
A
ILE
22
-144.07
-59.95
20
A
LYS
27
-122.46
-131.64
20
A
ARG
28
59.42
154.27
20
A
ARG
31
-161.12
97.61
BEST 20 NMR CONFORMERS OF D130I MUTANT T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA 2A ADRENERGIC RECEPTOR
1
N
N
A
THR
1
A
THR
1
HELX_P
A
TYR
15
A
TYR
15
1
1
15
MEMBRANE PROTEIN
HELIX-LINKER-HELIX, MEMBRANE PROTEIN
ADA2A_HUMAN
UNP
1
118
P08913
TSSIVHLCAISLDRYWSITQAIEYNLKRTPRR
118
149
1HO9
1
32
P08913
A
1
1
32
1
ASP
conflict
ILE
13
1HO9
A
P08913
UNP
130
13